News

Check out the latest news about Evidity Health Capital and our portfolio companies.

header-news-1278x1024
  • All
  • 2021
  • 2022

PreludeDxTM Closes $20 Million in Funding to Advance Growth Initiatives and Development of Its Precision Medicine Portfolio

Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics

Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio

Biotheranostics Announces Inclusion of Breast Cancer Index™ in the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines for Prediction of Benefit from Extended Endocrine Therapy

Hologic to Acquire Biotheranostics, Leader in Molecular Tests for Breast and Metastatic Cancers, for Approximately $230 Million